New! Technothrombin® TGA (Thrombin Generation Assay)
FOR IMMEDIATE RELEASE:
New! Technothrombin® TGA (Thrombin Generation Assay)
West Chester, OH, March 27, 2006 — DiaPharma introduces the Technothrombin® TGA kit, a global research test for investigation of bleeding and thrombotic tendency. This thrombin generation assay from Technoclone is based on monitoring the formation of thrombin with a fluorogenic substrate upon activation of the coagulation cascade by tissue factor (TF).
By providing varying amounts of TF and phospholipid, the Technothrombin® TGA is a universal tool for use in studying hemophilia during inhibitor bypassing therapy, pro-coagulant microparticles, anticoagulant drugs, and thrombophilia. The test can be performed with plasma or whole blood, in platelet rich plasma or platelet poor plasma.
The Technothrombin® TGA is a reliable global coagulation test suitable for investigating subjects for bleeding and thrombotic tendencies.
For more than 8 years, DiaPharma Group, Inc. has sold quality coagulation products to research, clinical and specialty testing laboratories. Today, the company continues to provide gold standard service and a full line of hemostasis products.
Contact DiaPharma at (800) 526-5224 or info@diapharma.com, or visit www.diapharma.com for additional information.
# # #
WebWireID13867
- Contact Information
- Jennifer Kiblinger
- Technical & Regulatory Affairs Manager
- DiaPharma Group, Inc.
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.